Novel anticancer activity of the autocleaved ovotransferrin against human colon and breast cancer cells

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 23, 2009, Pages 11383-11390

  Ibrahim, Hisham R ^a   Kiyono, Tohru ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Anticancer peptide therapy; Apoptosis; Autocleavage; Bio active peptides; Breast cancer; Colon cancer; Hen egg albumin; Kringle domain; Ovotransferrin; Tumoricidal activity

Indexed keywords

ANTINEOPLASTIC AGENT; OVOTRANSFERRIN;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CELL STRAIN HCT116; CHEMISTRY; CHICKEN; COLON TUMOR; DRUG EFFECT; HUMAN; PATHOPHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHICKENS; COLONIC NEOPLASMS; CONALBUMIN; HCT116 CELLS; HUMANS;

AVES;

EID: 72449167457     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf902638e     Document Type: Article

References (46)

1. Boonacker, E.; Van Noorden, C. J. The multifunctional or moonlighting protein CD26/DPPIV. Eur. J. Cell Biol. 2003, 82 (2), 53-73.
2. (2) Jeffery, C. J. Moonlighting proteins: old proteins learning new tricks. Trends Genet. 2003, 19 (8), 415-417. (Pubitemid 36930022)
3. Perler, F. B.; Xu, M. Q.; Paulus, H. Protein splicing and autoproteolysis mechanisms. Curr. Opin. Chem. Biol. 1997, 1 (3), 292-299.
4. Perler, F. B. Protein splicing of inteins and hedgehog autoproteolysis: structure, function, and evolution. Cell 1998, 92 (1), 1-4.
5. Lee, J. J.; Ekker, S. C.; von Kessler, D. P.; Porter, J. A.; Sun, B. I.; Beachy, P. A. Autoproteolysis in hedgehog protein biogenesis. Science 1994, 266 (5190), 1528-1537.
6. Stathakis, P.; Lay, A. J.; Fitzgerald, M.; Schlieker, C.; Matthias, L. J.; Hogg, P. J. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin. J. Biol. Chem. 1999, 274 (13), 8910-8916.
7. Davis, D. A.; Dorsey, K.; Wingfield, P. T.; Stahl, S. J.; Kaufman, J.; Fales, H. M.; Levine, R. L. Regulation of HIV-1 protease activity through cysteine modification. Biochemistry 1996, 35, 2482-2488.
8. Smith, G. K.; Barrett, D. G.; Blackburn, K.; Cory, M.; Dallas, W. S.; Davis, R.; Hassler, D.; McConnell, R.; Moyer, M.; Weaver, K. Expression, preparation, and high-throughput screening of caspase-8: discovery of redox-based and steroid diacid inhibition. Arch. Biochem. Biophys. 2002, 399 (2), 195-205.
9. Kim, J. S.; Chang, J. H.; Yu, H. K.; Ahn, J. H.; Yum, J. S.; Lee, S. K.; Jung, K. H.; Park, D. H.; Yoon, Y.; Byun, S. M.; Chung, S. I. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein. J. Biol. Chem. 2003, 278 (31), 29000-29008.
10. Shim, B. S.; Kang, B. H.; Hong, Y. K.; Kim, H. K.; Lee, I. H.; Lee, S. Y.; Lee, Y. J.; Lee, S. K.; Joe, Y. A. The kringle domain of tissuetype plasminogen activator inhibits in vivo tumor growth. Biochem. Biophys. Res. Commun. 2005, 327 (4), 1155-1162.
11. Wang, H.; Schultz, R.; Hong, J.; Cundiff, D. L.; Jiang, K.; Soff, G. A. Cell surface-dependent generation of angiostatin 4.5. Cancer Res. 2004, 64 (1), 162-168.
12. Lucas,R.;Holmgren,L.;Garcia,I.;Jimenez,B.;Mandriota,S.J.;Borlat,F.;Sim,B. K.;Wu,Z.;Grau,G.E.;Shing,Y.;Soff,G.A.;Bouck,N.;Pepper,M.S. Multipleformsofangiostatininduceapoptosisinendothelialcells.Blood1998,92(12), 4730-4741.(Pubitemid29005875)
13. Ibrahim, H. R. Ovotransferrin: chemistry and antimicrobial function. In Natural Food Antimicrobial Systems; Naidu, A. S., Ed.; CRC Press: Boca Raton, FL, 2000; pp 211-226.
14. (14) Carlevaro, M. F.; Albini, A.; Ribatti, D.; Gentili, C.; Benelli, R.; Cermelli, S.; Cancedda, R.; Cancedda, F. D. Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J. Cell Biol. 1997, 136 (6), 1375-1384. (Pubitemid 27421922)
15. Furlong, S. J.; Mader, J. S.; Hoskin, D. W. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen. Oncol. Rep. 2006, 15 (5), 1385-1390.
16. Mader, J. S.; Salsman, J.; Conrad, D. M.; Hoskin, D. W. Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines. Mol. Cancer Ther. 2005, 4 (4), 612-624.
17. Sala, R.; Jefferies, W. A.; Walker, B.; Yang, J.; Tiong, J.; Law, S. K.; Carlevaro, M. F.; Di Marco, E.; Vacca, A.; Cancedda, R.; Cancedda, F. D.; Ribatti, D. The human melanoma associated protein melanotransferrin promotes endothelial cell migration and angiogenesis in vivo. Eur. J. Cell Biol. 2002, 81 (11), 599-607.
18. Xie, H.; Huff, G. R.; Huff, W. E.; Balog, J. M.; Rath, N. C. Effects of ovotransferrin on chicken macrophages and heterophil-granulocytes. Dev. Comp. Immunol. 2002, 26 (9), 805-815.
19. Ibrahim, H. R.; Haraguchi, T.; Aoki, T. Ovotransferrin is a edoxdependent autoprocessing protein incorporating four consensus selfcleaving motifs flanking the two kringles. Biochim. Biophys. Acta 2006, 1760 (3), 347-355.
20. Gogvadze, V.; Sten Orrenius, S.; Zhivotovsky, B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 2008, 18 (4), 165-173.
21. Gillies, R. J.; Gatenby, R. A. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J. Bioenerg. Biomembr. 2007, 39, 251-257.
22. Stafforda, J. L.; Belosevica, M. Transferrin and the innate immune response of fish: identification of a novel mechanism of macrophage activation. Dev. Comp. Immunol. 2003, 27, 539-554.
23. Xiao, Y.; Monitto, C. L.; Minhas, K. M.; Sidransky, D. Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells. Clin. Cancer Res. 2004, 10 (24), 8683-8686.
24. Wolf, J. S.; Li, G.; Varadhachary, A.; Petrak, K.; Schneyer, M.; Li, D.; Ongkasuwan, J.; Zhang, X.; Taylor, R. J.; Strome, S. E.; O'Malley, B. W. Jr. Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clin. Cancer Res. 2007, 13 (5), 1601-1610.
25. Chandra Mohan, K. V.; Kumaraguruparan, R.; Prathiba, D.; Nagini, S. Modulation of xenobiotic-metabolizing enzymes and redox status during chemoprevention of hamster buccal carcinogenesis by bovine lactoferrin. Nutrition 2006, 22 (9), 940-946. (Pubitemid 44234018)
26. Baumrucker, C. R.; Schanbacher, F.; Shang, Y.; Green, M. H. Lactoferrin interaction with retinoid signaling: cell growth and apoptosis in mammary cells. Domest. Anim. Endocrinol. 2006, 30 (4), 289-303.
27. Richardson, D. R.; Baker, E. The uptake of iron and transferrin by the human malignant melanoma cell. Biochim. Biophys. Acta 1990, 1053, 1-12.
28. Leveugle, B.; Spik, G.; Perl, D. P.; Bouras, C.; Fillit, H. M.; Hof, P. R. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res. 1994, 650, 20-31.
29. (29) Davidson, D. J.; Haskell, C.; Majest, S.; Kherzai, A.; Egan, D. A.; Walter, K. A.; Schneider, A.; Gubbins, E. F.; Solomon, L.; Chen, Z.; Lesniewski, R.; Henkin, J. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer Res. 2005, 65 (11), 4663-4672. (Pubitemid 40740802)
30. Ibrahim, H. R.; Hoq, M. I.; Aoki, T. Ovotransferrin possesses SOD-like superoxide anion scavenging activity that is promoted by copper and manganese binding. Int. J. Biol. Macromol. 2007, 41 (5), 631-640.
31. Weydert, C. J.; Zhang, Y.; Sun, W.; Waugh, T. A.; Teoh, M. L.; Andringa, K. K.; Aykin-Burns, N.; Spitz, D. R.; Smith, B. J.; Oberley, L. W. Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth. Free Radical Biol. Med. 2008, 44 (5), 856-867.
32. Weydert, C. J.; Waugh, T. A.; Ritchie, J. M.; Iyer, K. S.; Smith, J. L.; Li, L.; Spitz, D. R.; Oberley, L. W. Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radical Biol. Med. 2006, 41, 226-237.
33. Raghunand, N.; Altbach, M. I.; Sluis, R. V.; Baggett, B.; Taylor, C. W.; Bhujwalla, Z. M.; Gillies, R. J. Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy. Biochem. Pharmacol. 1999, 57, 309-312.
34. Wike-Hooley, J. L.; Haveman, J.; Reinhold, H. S. The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 1984, 2, 343-366.
35. Stathakis, P.; Fitzgerald, M.; Matthias, L. J.; Chesterman, C. N.; Hogg, P. J. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells. J. Biol. Chem. 1997, 272 (33), 20641-20645.
36. Lincoln,D.T.;AliEmadi,E.M.;Tonissen,K.F.;Clarke,F.M.Thethioredoxin- thioredixinreductasesystem:over-expressioninhumancabcer.AnticancerRes.2003, 23(3B),2425-2433.(Pubitemid36897112)
37. Bradshaw, T. D.; Matthews, C. S.; Cookson, J.; Chew, E. H.; Shah, M.; Bailey, K.; Monks, A.; Harris, E.; Westwell, A. D.; Wells, G.; Laughton, C. A.; Stevens, M. F. Elucidation of thioredoxin as a molecular target for antitumor quinols. Cancer Res. 2005, 65, 3911-3919.
38. Chew, E. H.; Lu, J.; Bradshaw, T. D.; Holmgren, A. Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity. FASEB J. 2008, 22, 2072-2083. (Pubitemid 351811483)
39. Yang, X.; Cheng, R.; Li, C.; Cai, W.; Ma, J. X.; Liu, Q.; Yang, Z.; Song, Z.; Liu, Z.; Gao, G. Kringle 5 of human plasminogen suppresses hepatocellular carcinoma growth both in grafted and xenografted mice by anti-angiogenic activity. Cancer Biol. Ther. 2006, 5 (4), 399-405.
40. Victoria, L.; Mosiman, V. L.; Patterson, B. K.; Canterero, L.; Goolsby, C. L. Reducing cellular autofluorescence in flow cytometry: an in situ method. Cytometry 1997, 30, 151-156.
41. Morikawa, W.; Yamamoto, K.; Ishikawa, S.; Takemoto, S.; Ono, M.; Fukushi, J.; Naito, S.; Nozaki, C.; Iwanaga, S.; Kuwano, M. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. J. Biol. Chem. 2000, 275 (49), 38912-38920.
42. Tannock, I. F. Response of aerobic and hypoxic cells in a solid tumor to Adriamycin and cyclophosphamide and interaction of the drugs with radiation. Cancer Res. 1982, 42, 4921-4926.
43. Mader, J. S.; Hoskin, D. W. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin. Invest. Drugs 2006, 15 (8), 933-946.
44. Chen, T.; Wong, Y.-S. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation. Intl. J. Biochem. Cell Biol. 2009, 41, 666-676.
45. Ghobrial, I. M.; Witzig, T. E.; Adjei, A. A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 2005, 55, 178-194.
46. Kim, R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 2005, 103, 1551-1560. (Pubitemid 40490015)